UBX | Unity Biotechnology, Inc. Company profile
Company profileUNITY Biotechnology is developing therapeutics to extend human healthspan by slowing, halting or reversing diseases of aging. UNITY's initial focus is on creating senolytic medicines to selectively eliminate senescent cells and thereby treat age-related diseases, such as osteoarthritis, eye diseases and pulmonary diseases. About the CompanyUnity Biotechnology is a startup biotechnology company that develops drugs which target senescent cells. The company's products in development include UBX0101, targeting knee osteoarthritis, and UBX1967, a preclinical product targeting ophthalmologic diseases. Both are senolytic medicines. Address3280 Bayshore Boulevard Key Persons / Board of Directors
| NotesJump to (Finance sites)         ResearchInvestor pageir.unitybiotechnology.comIf you are looking for News & events, Press Release, they are available on their Investors Relationssite. Their Official Profiles   Other stocks            Support this projectIf you want to help pay for server cost or for improving this tool. You can send it via Paypal. Social MediaRecommended Books Buy on Amazon Want to know the strategies of successful swing trading? This friendly guide covers the ins and outs of this risky but profitable investing approach, explaining all the basics in plain English. You'll see how to use the two investment approaches - technical and fundamental analysis - to indentify promising securities in strongly trending markets. In addition, this guide covers how to calculate investment returns and, most important, how to manage your portfolio's risk. Take advantage of price swings in strongly trending securities and pump up your portfolio! |